⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

Official Title: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase IIb Study to Evaluate the Efficacy and Safety of Multiple Alvimopan Dosage Regimens for the Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Study ID: NCT00101998

Conditions

Constipation

Bowel Dysfunction

Interventions

alvimopan

placebo

Study Description

Brief Summary: A multicenter study to evaluate the effectiveness and safety of multiple dosage regimens of an investigational drug for the treatment of constipation due to prescription pain medication in subjects with cancer pain. The study will require five visits over a five-week period.

Detailed Description:

Keywords

OBD (Induced Bowel Dysfunction)

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

GSK Investigational Site, Tucson, Arizona, United States

GSK Investigational Site, Hot Springs, Arkansas, United States

GSK Investigational Site, Duarte, California, United States

GSK Investigational Site, Fountain Valley, California, United States

GSK Investigational Site, Fresno, California, United States

GSK Investigational Site, La Verne, California, United States

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, Los Gatos, California, United States

GSK Investigational Site, Modesto, California, United States

GSK Investigational Site, Sacramento, California, United States

GSK Investigational Site, San Diego, California, United States

GSK Investigational Site, Santa Monica, California, United States

GSK Investigational Site, Denver, Colorado, United States

GSK Investigational Site, Washington, D.C., District of Columbia, United States

GSK Investigational Site, Gainesville, Florida, United States

GSK Investigational Site, Inverness, Florida, United States

GSK Investigational Site, Lecanto, Florida, United States

GSK Investigational Site, Miami Shores, Florida, United States

GSK Investigational Site, New Port Richey, Florida, United States

GSK Investigational Site, Ocala, Florida, United States

GSK Investigational Site, Palm Harbor, Florida, United States

GSK Investigational Site, Stuart, Florida, United States

GSK Investigational Site, Tampa, Florida, United States

GSK Investigational Site, Titusville, Florida, United States

GSK Investigational Site, Decatur, Georgia, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, West Des Moines, Iowa, United States

GSK Investigational Site, Hutchinson, Kansas, United States

GSK Investigational Site, Baltimore, Maryland, United States

GSK Investigational Site, Bethesda, Maryland, United States

GSK Investigational Site, Boston, Massachusetts, United States

GSK Investigational Site, Worcester, Massachusetts, United States

GSK Investigational Site, Ann Arbor, Michigan, United States

GSK Investigational Site, Flint, Michigan, United States

GSK Investigational Site, Saint Louis Park, Minnesota, United States

GSK Investigational Site, Kansas City, Missouri, United States

GSK Investigational Site, Saint Louis, Missouri, United States

GSK Investigational Site, Reno, Nevada, United States

GSK Investigational Site, Albuquerque, New Mexico, United States

GSK Investigational Site, Bethpage, New York, United States

GSK Investigational Site, Huntington Station, New York, United States

GSK Investigational Site, Jamaica, New York, United States

GSK Investigational Site, Chapel Hill, North Carolina, United States

GSK Investigational Site, Charlotte, North Carolina, United States

GSK Investigational Site, Durham, North Carolina, United States

GSK Investigational Site, Hendersonville, North Carolina, United States

GSK Investigational Site, Raleigh, North Carolina, United States

GSK Investigational Site, Winston-Salem, North Carolina, United States

GSK Investigational Site, Bismarck, North Dakota, United States

GSK Investigational Site, Canton, Ohio, United States

GSK Investigational Site, Middletown, Ohio, United States

GSK Investigational Site, Portland, Oregon, United States

GSK Investigational Site, Nashville, Tennessee, United States

GSK Investigational Site, Amarillo, Texas, United States

GSK Investigational Site, Houston, Texas, United States

GSK Investigational Site, Webster, Texas, United States

GSK Investigational Site, Norfolk, Virginia, United States

GSK Investigational Site, Portsmouth, Virginia, United States

GSK Investigational Site, Richmond, Virginia, United States

GSK Investigational Site, Tacoma, Washington, United States

GSK Investigational Site, Milwaukee, Wisconsin, United States

GSK Investigational Site, Capital Federal, Buenos Aires, Argentina

GSK Investigational Site, Rosario, Santa Fe, Argentina

GSK Investigational Site, St Leonards, New South Wales, Australia

GSK Investigational Site, Redcliffe, Queensland, Australia

GSK Investigational Site, South Brisbane, Queensland, Australia

GSK Investigational Site, Daw Park, South Australia, Australia

GSK Investigational Site, Malvern, Victoria, Australia

GSK Investigational Site, Winnipeg, Manitoba, Canada

GSK Investigational Site, Saint John's, Newfoundland and Labrador, Canada

GSK Investigational Site, Kitchener, Ontario, Canada

GSK Investigational Site, London, Ontario, Canada

GSK Investigational Site, North Bay, Ontario, Canada

GSK Investigational Site, Oshawa, Ontario, Canada

GSK Investigational Site, Sudbury, Ontario, Canada

GSK Investigational Site, Bonaventure, Quebec, Canada

GSK Investigational Site, Chandler, Quebec, Canada

GSK Investigational Site, Levis, Quebec, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Sherbrooke, Quebec, Canada

GSK Investigational Site, Quebec, , Canada

GSK Investigational Site, Brno, , Czechia

GSK Investigational Site, Plzen, , Czechia

GSK Investigational Site, Praha 10, , Czechia

GSK Investigational Site, Helsinki, , Finland

GSK Investigational Site, Bordeaux Cedex, , France

GSK Investigational Site, Vandoeuvre-Les-Nancy, , France

GSK Investigational Site, Villejuif Cedex, , France

GSK Investigational Site, Goettingen, Niedersachsen, Germany

GSK Investigational Site, Goslar, Niedersachsen, Germany

GSK Investigational Site, Kwun Tong, , Hong Kong

GSK Investigational Site, Pokfulam, , Hong Kong

GSK Investigational Site, Shatin, , Hong Kong

GSK Investigational Site, Budapest, , Hungary

GSK Investigational Site, Miskolc, , Hungary

GSK Investigational Site, Zalaegerszeg-Pozva, , Hungary

GSK Investigational Site, Bangalore, , India

GSK Investigational Site, Caserta, Campania, Italy

GSK Investigational Site, Napoli, Campania, Italy

GSK Investigational Site, Forlì, Emilia-Romagna, Italy

GSK Investigational Site, Rimini, Emilia-Romagna, Italy

GSK Investigational Site, Genova, Liguria, Italy

GSK Investigational Site, Milano, Lombardia, Italy

GSK Investigational Site, Pavia, Lombardia, Italy

GSK Investigational Site, Busca (CN), Piemonte, Italy

GSK Investigational Site, Novara, Piemonte, Italy

GSK Investigational Site, Catania, Sicilia, Italy

GSK Investigational Site, Firenze, Toscana, Italy

GSK Investigational Site, Seoul, , Korea, Republic of

GSK Investigational Site, Leeuwarden, , Netherlands

GSK Investigational Site, Dunedin, , New Zealand

GSK Investigational Site, Hastings, , New Zealand

GSK Investigational Site, Wellington, , New Zealand

GSK Investigational Site, Lahore, , Pakistan

GSK Investigational Site, Lima, , Peru

GSK Investigational Site, Manila, , Philippines

GSK Investigational Site, Bialystok, , Poland

GSK Investigational Site, Olsztyn, , Poland

GSK Investigational Site, Otwock, , Poland

GSK Investigational Site, Poznan, , Poland

GSK Investigational Site, Lisboa, , Portugal

GSK Investigational Site, Moscow, , Russian Federation

GSK Investigational Site, St'Petersburg, , Russian Federation

GSK Investigational Site, Durban, KwaZulu- Natal, South Africa

GSK Investigational Site, Groenkloof, Pretoria, , South Africa

GSK Investigational Site, Houghton, Johannesburg, , South Africa

GSK Investigational Site, Kenilworth, Cape Town, , South Africa

GSK Investigational Site, Alcorcon, , Spain

GSK Investigational Site, Barcelona, , Spain

GSK Investigational Site, Cordoba, , Spain

GSK Investigational Site, Granada, , Spain

GSK Investigational Site, Jaén, , Spain

GSK Investigational Site, Madrid, , Spain

GSK Investigational Site, Sabadell / Barcelona, , Spain

GSK Investigational Site, Serra / Valencia, , Spain

GSK Investigational Site, Sevilla, , Spain

GSK Investigational Site, Soria, , Spain

GSK Investigational Site, Valencia, , Spain

GSK Investigational Site, Taipei, , Taiwan

GSK Investigational Site, Chiang Mai, , Thailand

GSK Investigational Site, London, , United Kingdom

GSK Investigational Site, Newcastle-upon-Tyne, , United Kingdom

GSK Investigational Site, Nottingham, , United Kingdom

GSK Investigational Site, Sheffield, , United Kingdom

GSK Investigational Site, Surrey, , United Kingdom

Contact Details

Name: GSK Clinical Trials, MD

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: